Anti-hepatoma activity of taxol in vitro

被引:0
作者
Yuan, JH
Wang, XW
Luo, D
Xie, Y
Xie, H [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Cell Biol, Shanghai 200031, Peoples R China
来源
ACTA PHARMACOLOGICA SINICA | 2000年 / 21卷 / 05期
关键词
taxol; hepatocellular carcinoma; cultured tumor cells; cell division; cell cycle; apoptosis;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
AIM: To investigate the in vitro anti-hepatoma activity of taxol against SMMC-7721 human hepatoma cells. METHODS: The hepatoma cell growth was measured by MTT-microculture tetrazolium assay. Cell-cycle kinetics and apoptosis were analyzed by flow cytometry and microscopic examination. RESULTS: Taxol inhibited the hepatoma cell growth in concentration- and time-dependent manners with IC50 Of 18.96 nmol.L-1. Marked cell accumulation in G(2)/M phase and multinucleated cells were also observed after treatment with taxol 10 nmol.L-1. In addition, taxol at 10 nmol.L-1 could induce the apoptosis of hepatoma cells. CONCLUSION: Taxol suppresses the growth of SMMC-7721 human hepatoma cells in vitro by causing cell-cycle arrest, aberrant mitosis, and apoptosis of the human hepatoma cells.
引用
收藏
页码:450 / 454
页数:5
相关论文
共 24 条
[1]   MICROTUBULE DEPENDENCY OF P34(CDC2) INACTIVATION AND MITOTIC EXIT IN MAMMALIAN-CELLS [J].
ANDREASSEN, PR ;
MARGOLIS, RL .
JOURNAL OF CELL BIOLOGY, 1994, 127 (03) :789-802
[2]   Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients [J].
Chao, Y ;
Chan, WK ;
Birkhofer, MJ ;
Hu, OYP ;
Wang, SS ;
Huang, YS ;
Liu, M ;
Whang-Peng, J ;
Chi, KH ;
Lui, WY ;
Lee, SD .
BRITISH JOURNAL OF CANCER, 1998, 78 (01) :34-39
[3]  
DANESI R, 1995, MOL PHARMACOL, V47, P1106
[4]  
DONALDSON KL, 1994, CELL GROWTH DIFFER, V5, P1041
[5]  
Dong RC, 1989, PRIMARY LIVER CANC, P145
[6]   Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines [J].
Gagandeep, S ;
Novikoff, PM ;
Ott, M ;
Gupta, S .
CANCER LETTERS, 1999, 136 (01) :109-118
[7]   Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines [J].
Johnson, SW ;
Shen, DW ;
Pastan, I ;
Gottesman, MM ;
Hamilton, TC .
EXPERIMENTAL CELL RESEARCH, 1996, 226 (01) :133-139
[8]   p53-independent apoptosis induced by paclitaxel through an indirect mechanism [J].
Lanni, JS ;
Lowe, SW ;
Licitra, EJ ;
Liu, JO ;
Jacks, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) :9679-9683
[9]  
Ling YH, 1998, INT J CANCER, V75, P925, DOI 10.1002/(SICI)1097-0215(19980316)75:6<925::AID-IJC16>3.0.CO
[10]  
2-1